195 related articles for article (PubMed ID: 12697117)
1. [Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis].
Wang Q; Jin PH; Lin GW; Xu SR; Chen J
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):135-9. PubMed ID: 12697117
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
Xie F; Luo N; Blackhouse G; Goeree R; Lee HP
Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
[TBL] [Abstract][Full Text] [Related]
4. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer.
Shin DW; Yun YH; Choi IJ; Koh E; Park SM
Helicobacter; 2009 Dec; 14(6):536-44. PubMed ID: 19889071
[TBL] [Abstract][Full Text] [Related]
7. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
8. Cost-benefit analysis of Helicobacter pylori screening.
Leivo T; Salomaa A; Kosunen TU; Tuominen R; Färkkilä M; Linna M; Sintonen H
Health Policy; 2004 Oct; 70(1):85-96. PubMed ID: 15312711
[TBL] [Abstract][Full Text] [Related]
9. [Study on health economics regarding the screening of gastric cancer in Zhuanghe high risk area].
Pan S; He QC; Zhou BS; Yuan Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):757-60. PubMed ID: 16536299
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
You JH; Wong PL; Wu JC
Scand J Gastroenterol; 2006 Jan; 41(1):21-9. PubMed ID: 16373272
[TBL] [Abstract][Full Text] [Related]
11. Asia-Pacific consensus guidelines on gastric cancer prevention.
Fock KM; Talley N; Moayyedi P; Hunt R; Azuma T; Sugano K; Xiao SD; Lam SK; Goh KL; Chiba T; Uemura N; Kim JG; Kim N; Ang TL; Mahachai V; Mitchell H; Rani AA; Liou JM; Vilaichone RK; Sollano J;
J Gastroenterol Hepatol; 2008 Mar; 23(3):351-65. PubMed ID: 18318820
[TBL] [Abstract][Full Text] [Related]
12. Should we screen for Helicobacter pylori to prevent gastric cancer?
Leja M; Dumitrascu DL
Dig Dis; 2007; 25(3):218-21. PubMed ID: 17827943
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS; Bandekar RR; Scheiman JM
Arch Intern Med; 1999 Jan; 159(2):142-8. PubMed ID: 9927096
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.
Xie F; Luo N; Lee HP
World J Gastroenterol; 2008 May; 14(19):3021-7. PubMed ID: 18494053
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
Pohl H; Finlayson SR; Sonnenberg A; Robertson DJ
Aliment Pharmacol Ther; 2005 Sep; 22(6):529-37. PubMed ID: 16167969
[TBL] [Abstract][Full Text] [Related]
16. [Could Helicobacter pylori treatment reduce stomach cancer risk?].
Bretagne JF
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):440-52. PubMed ID: 12700501
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
18. Significance of Helicobacter pylori infection and gastric cancer: implications for screening.
Moayyedi P; Dixon MF
Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):47-64. PubMed ID: 8995112
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Helicobacter pylori and prevention of gastric cancer.
Cheung TK; Wong BC
J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori public health implications.
Moayyedi P; Hunt RH
Helicobacter; 2004; 9 Suppl 1():67-72. PubMed ID: 15347308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]